These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25776495)

  • 1. miR-411 regulated ITCH expression and promoted cell proliferation in human hepatocellular carcinoma cells.
    Xia K; Zhang Y; Cao S; Wu Y; Guo W; Yuan W; Zhang S
    Biomed Pharmacother; 2015 Mar; 70():158-63. PubMed ID: 25776495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
    Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
    BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
    Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
    Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells.
    Zhou P; Huang G; Zhao Y; Zhong D; Xu Z; Zeng Y; Zhang Y; Li S; He F
    Cell Signal; 2014 Jun; 26(6):1347-54. PubMed ID: 24631531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.
    Yuan B; Liang Y; Wang D; Luo F
    Cancer Sci; 2015 Jul; 106(7):819-24. PubMed ID: 25940592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
    Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
    Biomed Pharmacother; 2016 Apr; 79():315-20. PubMed ID: 27044843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
    Yang XW; Shen GZ; Cao LQ; Jiang XF; Peng HP; Shen G; Chen D; Xue P
    BMC Cancer; 2014 Dec; 14():909. PubMed ID: 25472505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
    Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
    Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
    Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
    FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
    Lang Q; Ling C
    Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
    Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C
    Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.
    Shen H; Li W; Tian Y; Xu P; Wang H; Zhang J; Li Y
    J Cell Biochem; 2015 Aug; 116(8):1563-73. PubMed ID: 25649327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
    Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY
    Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma.
    Deng Q; Xie L; Li H
    Biochem Biophys Res Commun; 2015 Nov; 467(4):921-7. PubMed ID: 26474697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MafF Is Regulated via the circ-ITCH/miR-224-5p Axis and Acts as a Tumor Suppressor in Hepatocellular Carcinoma.
    Wu M; Deng X; Zhong Y; Hu L; Zhang X; Liang Y; Li X; Ye X
    Oncol Res; 2020 May; 28(3):299-309. PubMed ID: 31969212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.